Home Applications 218276 Application 218276
Type NDA
Sponsor NOVARTIS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 FABHALTA IPTACOPAN HYDROCHLORIDE CAPSULE;ORAL EQ 200MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N218276-001 FABHALTA IPTACOPAN HYDROCHLORIDE EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05
Orange Book patents# Current patent rows page 1 of 1 · 10 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N218276-001 10093663 2034-07-14 U-3980 2024-09-04 N218276-001 10093663 2034-07-14 U-4161 2024-09-04 N218276-001 9682968 2034-07-14 Drug substance, Drug product 2023-12-18 N218276-001 11723901 2038-08-30 U-3980 2024-09-04 N218276-001 12285422 2038-08-30 U-4181 2025-05-19 N218276-001 12384758 2041-05-17 U-3980 2025-08-20 N218276-001 12384758 2041-05-17 U-4161 2025-08-20 N218276-001 11603363 2041-05-25 Drug substance, Drug product 2023-12-18 N218276-001 11951101 2041-07-15 U-3895 2024-05-07 N218276-001 12453726 2041-07-15 U-4300 2025-11-04
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 5 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 1c564ffb4f44…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218276-001 FABHALTA EQ 200MG BASE CAPSULE / ORAL RLD, RS 2023-12-05 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 3 · 88 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N218276-001 10093663 2034-07-14 U-4161 2024-09-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218276-001 10093663 2034-07-14 U-3980 2024-09-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218276-001 9682968 2034-07-14 Drug substance, Drug product 2023-12-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218276-001 11723901 2038-08-30 U-3980 2024-09-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218276-001 12285422 2038-08-30 U-4181 2025-05-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218276-001 12384758 2041-05-17 U-3980 2025-08-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218276-001 12384758 2041-05-17 U-4161 2025-08-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218276-001 11603363 2041-05-25 Drug substance, Drug product 2023-12-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218276-001 11951101 2041-07-15 U-3895 2024-05-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N218276-001 12453726 2041-07-15 U-4300 2025-11-04 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218276-001 10093663 2034-07-14 U-4161 2024-09-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218276-001 10093663 2034-07-14 U-3980 2024-09-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218276-001 9682968 2034-07-14 Drug substance, Drug product 2023-12-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218276-001 11723901 2038-08-30 U-3980 2024-09-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218276-001 12285422 2038-08-30 U-4181 2025-05-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218276-001 12384758 2041-05-17 U-3980 2025-08-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218276-001 12384758 2041-05-17 U-4161 2025-08-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218276-001 11603363 2041-05-25 Drug substance, Drug product 2023-12-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218276-001 11951101 2041-07-15 U-3895 2024-05-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218276-001 12453726 2041-07-15 U-4300 2025-11-04 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218276-001 10093663 2034-07-14 U-4161 2024-09-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218276-001 10093663 2034-07-14 U-3980 2024-09-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218276-001 9682968 2034-07-14 Drug substance, Drug product 2023-12-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218276-001 11723901 2038-08-30 U-3980 2024-09-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218276-001 12285422 2038-08-30 U-4181 2025-05-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218276-001 11603363 2041-05-25 Drug substance, Drug product 2023-12-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N218276-001 11951101 2041-07-15 U-3895 2024-05-07 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218276-001 10093663 2034-07-14 U-3980 2024-09-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218276-001 9682968 2034-07-14 Drug substance, Drug product 2023-12-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218276-001 11723901 2038-08-30 U-3980 2024-09-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218276-001 11603363 2041-05-25 Drug substance, Drug product 2023-12-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218276-001 11951101 2041-07-15 U-3895 2024-05-07 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218276-001 10093663 2034-07-14 U-3980 2024-09-04 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218276-001 9682968 2034-07-14 Drug substance, Drug product 2023-12-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218276-001 11723901 2038-08-30 U-3980 2024-09-04 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218276-001 11603363 2041-05-25 Drug substance, Drug product 2023-12-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218276-001 11951101 2041-07-15 U-3895 2024-05-07 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218276-001 10093663 2034-07-14 U-3980 2024-09-04 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218276-001 9682968 2034-07-14 Drug substance, Drug product 2023-12-18 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218276-001 11723901 2038-08-30 U-3980 2024-09-04 03ed91905a0d…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 50 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join FABHALTA IPTACOPAN Novartis Pharmaceuticals Corporation a76b5845-6e21-4d3b-ad07-cd8df1b60bee 2026-07-16 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 218276 application number: NDA218276
Documents# Document, Submission type, Date table Document Submission type Date 81681 SUPPL 2025-03-24 81662 SUPPL 2025-03-20 81661 SUPPL 2025-03-20 79352 SUPPL 2024-08-09 79326 SUPPL 2024-08-07 78565 SUPPL 2024-05-28 77999 SUPPL 2024-03-27 77981 SUPPL 2024-03-27 77151 ORIG 2023-12-27 76744 ORIG 2023-12-06 76739 ORIG 2023-12-06